SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                               -------------------

                                   FORM 10-QSB

                   QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934
                               -------------------

     For Quarter Ended September 30, 2001      Commission File No. 0-29804

                                 eClickMD, INC.
               (Exact name of registrant as specified in charter)

           Nevada                                         82-0255758
           ------                                         ----------
      (State or Jurisdiction                             (IRS Employee
        Of Incorporation)                           Identification Number)

 201 East Main Street, Brady Texas                          78625
----------------------------------                          -----
(Address of Principal Executive Offices)                  (Zip Code)


       Registrant's Telephone Number, Including Area Code: (915) 792-8400
                                                           --------------


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                             YES [X]       NO [ ]

As of September 30, 2001, there were 14,868,325 shares of common stock, $.001
par value, of the registrant issued and outstanding.

Transitional Small Business Disclosure Format (check one)

YES [ ]  NO [X]
<PAGE>

                         eCLICKMD, INC. AND SUBSIDIARIES
                   (Formerly Link.com, Inc. and Subsidiaries)
                     (Formerly Center Star Gold Mines, Inc.)

                               September 30, 2001

                                      INDEX

                                                                        Page No.
                                                                        --------

PART I   FINANCIAL INFORMATION

         Item 1.  Financial Statements

                  Consolidated Balance Sheets as of September 30, 2001
                  (unaudited) and December 31, 2000                            2

                  Consolidated Statements of Operations (unaudited)for
                  the three months ended September 30, 2001 and 2000           3

                  Consolidated Statements of Operations (unaudited)for
                  the nine months ended September 30, 2001 and 2000            4

                  Consolidated Statements of Cash Flows (unaudited)for
                  the nine months ended  September 30, 2001 and 2000           5

                  Notes to Consolidated Financial Statements (unaudited)       6

         Item 2.  Management's Discussion and Analysis or Plan of Operation    8

PART II  OTHER INFORMATION

         Item 1. Legal Proceedings                                            12

         Item 2. Changes in Securities and Use of Proceeds                    12

         Item 3. Defaults Upon Senior Securities                              13

         Item 4. Submission of Matters to a Vote of Security Holders          13

         Item 5. Other Information                                            13

         Item 6. Exhibits and Reports on Form 8-K                             13

SIGNATURES                                                                    14
<PAGE>

<TABLE>
<CAPTION>
                         eCLICKMD, INC. AND SUBSIDIARIES
                   (Formerly Link.com, Inc. and Subsidiaries)
                     (Formerly Center Star Gold Mines, Inc.)

                           CONSOLIDATED BALANCE SHEETS
               September 30, 2001(unaudited) and December 31, 2000

                                     ASSETS
                                     ------

                                                                      September 30,   December 31,
                                                                          2001           2000
                                                                       -----------    -----------
<S>                                                                    <C>            <C>
Current assets
   Cash and cash equivalents                                           $    22,020    $     6,599
   Accounts receivable - trade, net of allowance for doubtful
   accounts of $38,725 and $31,451 at September 30, 2001
   and December 31, 2000, respectively                                      42,651         12,056
   Prepaid expenses and other  current assets                                8,645            351
                                                                       -----------    -----------
   Total current assets                                                     73,316         19,006

Property and equipment, net of accumulated depreciation                    290,730        405,931

Deferred financing fees, net of accumulated amortization                       176         81,012
                                                                       -----------    -----------

   Total assets                                                        $   364,222    $   505,949
                                                                       ===========    ===========

                      LIABILITIES AND SHAREHOLDERS' DEFICIT
                      -------------------------------------

Current liabilities
   Bank overdraft                                                      $        --    $    37,240
   Line of credit                                                          400,000        400,000
   Current notes payable (including of $169,809 and
    $155,000 owed to related parties at September 30, 2001
     and December 31, 2000, respectively)                                  260,250        185,705
   Convertible notes and debentures - current maturities                   313,615      2,004,100
    Deferred revenue and customer deposits                                  42,200         18,830
    Payable to related parties                                             348,368        169,174
    Accounts payable                                                       956,636        876,802
    Accrued liabilities                                                    376,893        187,064
                                                                       -----------    -----------
    Total current liabilities                                            2,697,962      3,878,915

Long-term convertible notes payable                                        896,158             --

Shareholders' deficit
   Preferred stock - $0.001 par value; 15,000,000 shares authorized,
   no shares issued and outstanding                                             --             --
   Common stock - $0.001 par value; 50,000,000 shares authorized,
   14,868,325 and 11,875,289 shares issued and outstanding
   at September 30, 2001 and December 31, 2000, respectively                14,870         11,875
   Additional paid-in capital                                            2,826,625      1,313,748
   Receivable for the purchase of equity                                  (193,294)        (2,000)
   Accumulated deficit                                                  (5,878,099)    (4,696,589)
                                                                       -----------    -----------
   Total shareholders' deficit                                          (3,229,898)    (3,372,966)
                                                                       -----------    -----------

   Total liabilities and shareholders' deficit                         $   364,222    $   505,949
                                                                       ===========    ===========
</TABLE>
See notes to interim financial statements.

                                       2
<PAGE>

<TABLE>
<CAPTION>

                         eCLICKMD, INC. AND SUBSIDIARIES
                   (Formerly Link.com, Inc. and Subsidiaries)
                     (Formerly Center Star Gold Mines, Inc.)

                CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
             For the Three Months Ended September 30, 2001 and 2000


                                                    2001           2000
                                                ------------    ------------
<S>                                             <C>             <C>
Revenues                                        $     96,485    $    111,354

Operating expenses:
   Cost of service                                    19,112          74,515
   Research and development costs                     46,697         121,088
   Selling, general and administrative              329,278         735,842
                                                ------------    ------------
    Operating loss                                  (298,602)       (820,091)

Other income                                           2,261              13
Interest expense                                     (39,044)        (66,850)
                                                ------------    ------------

    Net loss                                    $   (335,385)   $   (886,928)
                                                ============    ============

Net loss per common share - basic and diluted   $      (0.02)   $      (0.08)
                                                ============    ============

Weighted-average number of common shares
    outstanding - basic and diluted               14,344,396      11,256,111
                                                ============    ============
</TABLE>

See notes to interim financial statements.

                                       3
<PAGE>

<TABLE>
<CAPTION>

                         eCLICKMD, INC. aND SUBSIDIARIES
                   (Formerly Link.com, Inc. and Subsidiaries)
                     (Formerly Center Star Gold Mines, Inc.)

                CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
              For the Nine Months Ended September 30, 2001 and 2000


                                                    2001             2000
                                                ------------    ------------
<S>                                             <C>             <C>
Revenues                                        $    322,641    $    246,853

Operating expenses:
   Cost of service                                    76,011         152,380
   Research and development costs                    203,956         304,761
   Selling, general and administrative             1,054,018       2,082,530
                                                ------------    ------------
       Operating loss                             (1,011,344)     (2,292,818)

Other income                                           2,337             588
Interest expense                                    (172,503)       (159,040)
                                                ------------    ------------

       Net loss                                 $ (1,181,510)   $ (2,451,270)
                                                ============    ============

Net loss per common share - basic and diluted   $      (0.09)   $      (0.22)
                                                ============    ============

Weighted-average number of common shares
       outstanding- basic and diluted             12,974,275      11,159,444
                                                ============    ============
</TABLE>

See notes to interim financial statements.

                                       4
<PAGE>

<TABLE>
<CAPTION>
                         eCLICKMD, INC. AND SUBSIDIARIES
                   (Formerly Link.Com, Inc. and Subsidiaries)
                     (Formerly Center Star Gold Mines, Inc.)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
For the Nine Months Ended September 30, 2001 and 2000

                                                              2001           2000
                                                          -----------    -----------
<S>                                                       <C>            <C>
Cash flows from operating activities
   Net loss                                               $(1,181,510)   $(2,451,270)
   Adjustments to reconcile net loss to net cash used
      in operating activities:
      Depreciation                                            116,132         20,225
      Provision for Bad Debts                                  19,653         23,875
      Write-off of bad debts                                  (12,378)            --
      Stock issued for services                                39,350             --
      Issuance of stock in lieu of interest                        --         20,797
      Amortization of deferred financing fees                  80,836             --
   Increases and decreases in working capital accounts:
      Bank overdraft                                          (37,240)            --
      Accounts receivable - trade                             (37,870)       (82,092)
      Prepaid expenses and other current assets                (8,296)            --
      Customer deposits                                        23,370             --
      Accounts payable                                        218,711        217,870
      Accrued liabilities                                     365,534         14,337
                                                          -----------    -----------
      Cash flows used in operating activities                (413,708)    (2,236,258)

Cash flows from investing activities
   Purchases of property and equipment                           (932)      (103,732)
                                                          -----------    -----------
      Cash flows used in investing activities                    (932)      (103,732)

Cash flows from financing activities
   Payments on convertible notes payable and debentures            --        (13,000)
   Borrowings on convertible notes payable                    147,350      1,736,100
   Payable to related parties                                 179,194         90,000
   Payments to related parties                                     --        (98,503)
   Payments received on advances to related parties                --         53,500
   Exercise of stock options                                   28,972             --
   Borrowings on notes payable                                 74,545             --
                                                          -----------    -----------
      Cash flows provided by financing activities             430,061      1,768,097
                                                          -----------    -----------

Net increase (decrease) in cash                                15,421       (571,893)

Cash, beginning of period                                       6,599        576,424
                                                          -----------    -----------

Cash, end of period                                       $    22,020    $     4,531
                                                          ===========    ===========

Supplemental disclosures for cash flow information:
   Cash paid during the period for:
      Interest                                            $     9,035    $   141,176
                                                          ===========    ===========

      Income taxes                                        $        --    $        --
                                                          ===========    ===========


Non-cash investing and financing activities:
  Purchase of Health Tech, Inc. with equity                        --         69,264
                                                          ===========    ===========
      Conversion of notes payable to common stock         $ 1,256,259    $ 1,041,750
                                                          ===========    ===========
      Issuance of stock for notes receivable              $   191,292    $        --
                                                          ===========    ===========
</TABLE>

See notes to interim financial statements.

                                       5
<PAGE>

                         eCLICKMD, INC. AND SUBSIDIARIES
                   (Formerly Link.com, Inc. and Subsidiaries)
                     (Formerly Center Star Gold Mines, Inc.)

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
         For the Three and Nine Months Ended September 30, 2001 and 2000


1.       BASIS OF PRESENTATION

The interim financial statements of eClickMD, Inc. and Subsidiaries (the
"Company" or "eClickMD") at September 30, 2001, and for the three and nine
months ended September 30, 2001 and 2000, are unaudited, and include all
adjustments (consisting only of normal recurring adjustments) which the Company
considers necessary for a fair presentation. The December 31, 2000 balance sheet
was derived from the balance sheet included in the Company's audited financial
statements as filed on Form 10-KSB for the year ended December 31, 2000. Certain
amounts previously reported in prior interim financial statements have been
reclassified to conform to the 2001 presentation.

The accompanying unaudited interim financial statements are for interim periods
and do not include all disclosures normally provided in annual financial
statements, and should be read in conjunction with the Company's audited
financial statements. The accompanying unaudited interim financial statements
for the three and nine months ended September 30, 2001, are not necessarily
indicative of the results which can be expected for the entire fiscal year.

2.       GOING CONCERN

The consolidated financial statements for the three and nine months ended
September 30, 2001 and year ended December 31, 2000 were prepared on the
assumption that the Company will continue as a going concern. The Company's
continued existence depends upon the success of management's efforts to raise
additional capital necessary to meet the Company's obligations as they come due
and to obtain sufficient capital to execute its business plan. The Company
intends to obtain capital primarily through issuances of equity and convertible
debt. Additionally, the Company intends to renew its line of credit agreement.
There can be no degree of assurance given that the Company will be successful in
completing additional financing transactions.

The consolidated financial statements do not include any adjustments to reflect
the possible effects on the recoverability and classification of assets or
classification of liabilities that may result from the inability of the Company
to continue as a going concern.

3.       CONVERTIBLE NOTES PAYABLE

In 2000 and the first nine months of 2001, the Company issued convertible notes
payable totaling $1,991,200 to approximately 15 individuals. The notes which
bear interest at 10% have original maturity dates of three to twelve months and
expire through March, 2002. The notes are convertible into preferred shares of
the Company.

In the second quarter of 2001, holders of 10% convertible notes payable totaling
$1,841,100 inclusive of accrued interest were given an Offer of Conversion which
allows the note holder to convert to 920,550 shares common stock, based upon a
$2.00 per share stock price. At June 30,2001 notes totaling $1,161,100 plus
$95,159 in accrued interest converted to 628,030 shares of common stock. In the
third quarter of 2001, holders of convertible notes payable and accrued interest
payable totaling $701,725 with current term maturities were exchanged for
long-term convertible notes payable with 10% and 12% interest payable with
interest due quarterly. These notes have maturity dates in February of 2003.
Accrued interest totaling $63,821 was exchanged for an eighteen month note
payable with monthly amortized payments at 12% interest. Accounts payable
totaling $138,877 were converted into a convertible note payable with 10%
interest due in February of 2003.

                                       6
<PAGE>

4.       SUBSEQUENT EVENT

In September of 2001, the company signed a private placement agreement for a
private placement transaction which is continuing and may raise gross proceeds
of up to $1,250,000. On October 3, 2001, the company issued senior promissory
convertible notes to a private investment fund for $500,000 with interest at 5%
annually. After payment of placement agent commissions and expenses of this
offering, the company realized net proceeds of approximately $445,000. The
notes, which are convertible into common shares have a term of 24 months. Also
issued in connection with these notes are warrants to purchase an aggregate of
421,348 common shares at $1.75 per share. The placement is ongoing and the
Company may realize additional proceeds therefrom.

Subsequent to September 30, 2001, convertible notes payable representing $63,000
from three individuals matured and are in default. The Company is seeking terms
of repayment or extension from these individuals.

5.       TREATMENT OF CERTAIN STOCK OPTIONS FOR DISPUTED SERVICES

In July 2001, the Company issued stock options as retainers for services and as
collateral for financing in connection with such services to Oxford Financial
and Mark Anthony Christini which were subsequently converted into common stock.
In September, 2001, the Company filed a complaint against Oxford Venture Fund,
L.L.C. and Karim Rajani alleging the defendants had received Company stock
options to purchase 275,000 shares as a retainer and for the purpose of
collateralizing financing for the Company, and that the defendant then sold a
portion of the stock thereby converting it to their own use instead of using it
for collateral. The Company sought compensatory damages, exemplary damages and
injunctive relief. The defendant's appeared for a hearing to argue against the
Court's in personam jurisdiction over them as well as to argue against the need
for injunctive relief. On September 14, 2001, the Court granted a temporary
injunction against the defendants making sales of the Company's stock. At the
date of this filing, 1,800,000 shares are being restricted from transfer of
which 600,000 shares are being held in certificate form by the transfer agent.
The defendants have not filed their answer in this matter and the Company
intends to seek a default judgment against the defendants. The Company also
issued options to purchase an aggregate of 275,000 shares to Mark Anthony
Christini as a retainer in exchange for legal services associated with Oxford
Venture Fund. These options were converted to shares of common stock.
Subsequently, Mr. Christini became deceased before any services were rendered.
The Company plans to seek recovery of such shares from the estate of Mr.
Christini. The Company expects to recover the before mentioned shares. Due to
the circumstances surrounding the issuance of the options and the subsequent
dispute that has arisen due to the failure of the optionees to perform according
to the agreement, no value has been recorded in the accompanying financial
statements related to the original issuance of the options. In the event that
the shares may not be recovered, the Company may incur an associated expense
during the reporting period in which the settlement occurs.

                                       7
<PAGE>

Item 2.  Management's Discussion and Analysis or Plan of Operation


         Forward Looking Statements

         This Quarterly Report on Form 10-QSB contains "forward-looking"
statements as such term is defined in the Private Securities Litigation Reform
Act of 1995 and information relating to the Company and its subsidiaries that
are based on the beliefs of the Company's management as well as assumptions made
by and information currently available to the Company's management. When used in
this report, the words "anticipate," "believe," "estimate," "expect" and
"intend" and words or phrases of similar import, as they relate to the Company
or its subsidiaries or Company management, are intended to identify
forward-looking statements. Such statements reflect the current risks,
uncertainties and assumptions related to certain factors including, without
limitations, competitive factors, general economic conditions, customer
relations, relationships with vendors, the interest rate environment,
governmental regulation and supervision, seasonality, distribution networks,
product introductions and acceptance, technological change, changes in industry
practices, one-time events and other factors described herein and in other
filings made by the company with the Securities and Exchange Commission, based
upon changing conditions, should any one or more of these risks or uncertainties
materialize, or should any underlying assumptions prove incorrect, actual
results may vary materially from those described herein as anticipated,
believed, estimated, expected or intended. The Company does not intend to update
these forward-looking statements.


         Overview

         The Company's business is connecting physicians, home health agencies
and nursing homes via electronic medical records ("EMR") products and services.
The Company has developed a systems solution that transforms the EMR into an
interactive document. This paperless communication between the provider and
physician is achieved through electronic order and signature software, which can
be layered onto Internet communications, enterprise systems, databases, and
other technology. The physician can review the EMR and return to the provider,
with signatures, through this paperless system. The software also allows the
physician to electronically track and bill for Care Plan Oversight ("CPO"); the
time a physician can bill per month per patient. Many physicians overlook the
CPO billings, primarily due to the increased paperwork to manually track the
billing. The Company's ClickMD software automatically tracks the time spent and
produces reports that can be used as the source document for billing.

         The Company has developed and intends to provide a broad range of
Web-based healthcare electronic commerce services that will improve
communication among physicians, suppliers, and other providers; however, there
can be no assurance given that the Company will be successful in its product
deployment efforts. These services using Internet technology in the healthcare
electronic commerce industry are subject to risks,

                                       8
<PAGE>

including but not limited to those associated with competition from existing
companies offering similar services, rapid technological change, development
risks, management of growth and a minimal previous record of operations or
earnings.


         Results of Operations

Three Months Ended September 30, 2001 Compared to Three Months Ended September
30, 2000

         Revenues for the three months ended September 30, 2001 were $96,485
compared to $111,354 in the same period in 2000, a 13% decrease in revenue from
comparable periods. The decrease in revenue was primarily attributable to
decreased marketing activity in 2001. Since converting its products to a
browser-based ASP application in October, 2000, the Company has focused its
operational and marketing activities toward migration of its current customer
base from its original DocLink products to its ClickMD ASP applications. During
the period ended September 30, 2001, the Company has initiated several pilot
programs with new clients for evaluation prior to a prospective system-wide
implementation.

         Operating expenses were $395,087 for the three months ended September
30, 2001 compared to $931,445 for the three months ended September 30, 2000, a
decrease of 58%. The decrease in operating expenses was primarily attributable
to a reduction in salaries and marketing expenses from the comparable period of
2000. Research and development costs were $46,697 and $121,088 for the three
months ended September 30, 2001 and 2000, respectively. The decrease is
primarily due to personnel cutbacks in the research and development department.

         Interest expense for the quarter ended September 30, 2001 was $39,044
compared to $66,850 in 2000. Decreases in interest expense resulted primarily
from conversion of a portion of convertible notes payable to common shares in
2001. Issuance of convertible notes payable in 1999 and 2000 provided funding
for product development and marketing of the company's browser-based product
line.

Nine Months Ended September 30, 2001 Compared to Nine Months Ended September 30,
2000

         Revenues for the nine months ended September 30, 2001 were $322,641
compared to $246,853 in the same period in 2000. The 31% increase in revenue for
comparable periods was primarily attributable to increased sales in the second
quarter of 2001.

         Operating expenses were $1,333,985 for the nine months ended September
30, 2001 compared to $2,539,671 for the nine months ended September 30, 2000.
The 47% decrease in operating expenses was primarily attributable to a reduction
in salaries and marketing expenses from the comparable period of 2000. During
the 2000 reporting period, the Company closed offices in Nashville, Tennessee
and reduced management and other salary expenditures to conserve cash resources.

                                       9
<PAGE>

         Interest expense for the nine months ended September 30, 2001 was
$172,503 compared to $159,040 in 2000. This increase was the result of
borrowings from long-term debt incurred in September 1999 to fund increased
marketing and product development of the Company's product lines.


         Liquidity and Capital Resources

         In 1999 and the first quarter of 2000, the Company raised $1.2 million
in long-term convertible debentures to increase the marketing and visibility of
its original product, DocLink. In the third quarter of 2000, debentures of
$1,041,750 elected to convert their debentures and accrued interest into
approximately 619,000 shares of the Company's common stock.

         In 2000, the Company raised $1,841,100 in the form of a convertible
notes with maturities ranging from ninety days to one year. During the first
quarter of 2001, additional notes totaling $150,100 were issued. Such notes are
convertible into Preferred Stock of the Company which became available in
September 2000. Cash provided by these financings provided the primary source of
funding for the period ended September 30, 2001

         In the second quarter of 2001, holders of 10% convertible notes payable
totaling $1,841,100 were given an Offer of Conversion which allows the note
holder to convert to 920,550 shares common stock, based upon a $2.00 per share
stock price. Notes payable (including accrued interest) totaling $1,256,259 were
converted to 628,030 shares of common stock during the first half of the year.

         In the third quarter of 2001, holders of convertible notes payable and
accrued interest payable totaling $701,725 with current term maturities were
exchanged for long-term convertible notes payable with 10% and 12% interest
payable with interest due quarterly. These notes have maturity dates in February
of 2003. Accrued interest totaling $63,821 was exchanged for an eighteen month
note payable with monthly amortized payments at 12% interest. Accounts payable
totaling $138,877 were converted into a convertible note payable with 10%
interest due in February of 2003.

         In September of 2001, the company signed a private placement agreement
for a private placement transaction which is continuing and may raise gross
proceeds of up to $1,250,000. On October 3, 2001, the company issued senior
promissory convertible notes to a private investment fund for $500,000 with
interest at 5% annually. The notes, which are convertible into common shares
have a term of 24 months. Also issued in connection with these notes are
warrants to purchase and aggregate of 421,348 common shares at $1.75 per share.
After payment of placement agent commissions and expenses of this offering, the
company realized net proceeds of approximately $445,000. The placement is
ongoing and the Company may realize additional proceeds therefrom.

                                       10
<PAGE>

         The Company has a line of credit at a bank in the amount of $400,000
that is currently fully borrowed. The line of credit has a maturity date of
October 2001.

         The Company has limited cash resources and intends to raise additional
capital through convertible notes and the issuance of preferred stock or
additional common stock. The Company believes the additional capital will allow
it to continue its marketing efforts in its core products and develop and add
new functional enhancements to the browser-based versions of its products. The
availability of cash through such resources is not assured and if the Company is
not able to raise enough cash to complete these goals, the outcome will be
uncertain.

         The consolidated financial statements have been prepared on the
assumption that the Company will continue as a going concern. The Company's
continued existence depends upon the success of management's efforts to raise
additional capital necessary to meet the Company's obligations as they come due
and to obtain sufficient capital to execute its business plan. There can be no
degree of assurance given that the Company will be successful in completing
additional financing transactions.

         The consolidated financial statements do not include any adjustments to
reflect the possible effects on the recoverability and classification of assets
or classification of liabilities which may result from the inability of the
Company to continue as a going concern.

                                       11
<PAGE>

                                     PART II

                                OTHER INFORMATION

Item 1.  Legal Proceedings
--------------------------------------------------------------------------------

Cause No. GN100323; 200th Judicial District Court of Travis County, Texas.
AmeriQuest Technologies, Inc. vs. eClickMD, Inc., filed January 31, 2001.
Lawsuit for collection of purchase price of computer equipment purchased by
eClickMD, Inc. totaling approximately $260,000. Subsequent to September 30, the
company has submitted a lease agreement and payments to initiate a new lease
program on the above mentioned equipment. At the date of this filing the lease
agreement is under negotiation.

Cause No.01GC5772; Davidson County Tennessee General Sessions Court. Dye Van
Moll & Lawrence, Inc. vs. eClickMD, Inc. The lawsuit, filed on March 22,2001,
involved alleged breach of contract regarding marketing, advertising and
consulting contract.  On August 15, 2001 the Company reached a settlement on
cause No.01GC5772; Davidson County Tennessee General Sessions Court, Dye Van
Moll & Lawrence, Inc. vs. eClickMD, Inc. The lawsuit involving an alleged breach
of contract regarding marketing, advertising and consulting contract was settled
for $6,500 plus court costs.

Cause No. 3:OLV343LN:United States District Court, Southern District of
Mississippi. David Buck vs eClickMD. The lawsuit, filed on May 8, 2001 alleges
breaches of severence in an employment agreement. David Buck is seeking damages
of up to $197,200.

On October 17, 2001, in the United States District Court, Western District of
Texas, Austin Division, the Company filed a counter suit against David Buck,
Philip Mattingly, and John Griffin for breach of fiduciary duty, statutory and
common law fraud, and conversion of corporate funds and assets. One or more of
the defendants have been served. No defendant has answered to date.

Cause No. A 01 CA 599 SS; United States District Court, Western District of
Texas, Austin Division. eClickMD, Inc. v. Oxford Venture Fund, L.L.C. and Karim
Rajani. On September 14, 2001, the Company filed a complaint alleging the
defendants had received Company stock valued at over $1,525,000 for the purpose
of collateralizing financing for the Company. The defendant sold a portion of
the stock thereby converting it to their own use instead of using it for
collateral. The Company sought compensatory damages, exemplary damages and
injunctive relief. The defendant's appeared for a hearing to argue against the
Court's in personam jurisdiction over them as well as to argue against the need
for injunctive relief. On September 14, 2001, the Court granted a temporary
injunction against the defendants making sales of the Company's stock. At the
date of this filing, 1,800,000 shares are being restricted from transfer of
which 600,000 shares are held in certificate form by the transfer agent. The
defendants have not filed their answer in this matter and the Company intends to
seek a default judgment against the defendants.

Item 2.       Changes in Securities
--------------------------------------------------------------------------------

None.

                                       12
<PAGE>

Item 3.       Defaults Upon Senior Securities
--------------------------------------------------------------------------------

None.

Item 4.       Submission of Matters to a Vote of Security Holders
--------------------------------------------------------------------------------

None.

Item 5.       Other Information
--------------------------------------------------------------------------------

None.

Item 6.       Exhibits and Reports on Form 8-K
--------------------------------------------------------------------------------

a)   EXHIBITS
None.

b)   REPORTS ON FORM 8-K
None.

                                       13
<PAGE>

                                   SIGNATURES

         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.


eClickMD, Inc.

Date:  November 14, 2001                    By: /s/ MARION ROBERT RICE
                                               ------------------------
                                               Marion Robert Rice,
                                               President and CEO
                                               (Principal Executive, Financial
                                               and Accounting Officer)

         Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

         NAME                             TITLE                 DATE SIGNED

By: /s/ MARION ROBERT RICE      Director, CEO and President   November 14, 2001
    ----------------------
    Marion Robert Rice

By: /s/ ANDY W. MCBEE           Director and Assistant        November 14, 2001
    ----------------------      Secretary
    Andy W. McBee

By: /s/ RICHARD F. CORLIN       Director                      November 14, 2001
    ---------------------
    Richard F. Corlin, MD

By: /s/ GARY HUMBERSON          Director                      November 14, 2001
    ---------------------
    Gary Humberson

                                       14